Answers are grounded in this paper and cite their sources.
Although post-ischemic stroke process is essential for the repair of the infarcted area, excessive inflammation during this process can induce tissue damage. Damage-associated molecular patterns (DAMPs) released from injured cells in the early phase of ischemic stroke induce cytokine and chemokine production by activating microglia, thereby facilitating neutrophil and lymphocyte infiltration. However, the inhibition of neutrophils, lymphocytes, and their associated proinflammatory molecules has shown no apparent improvement in the functional outcomes and prognosis of post-ischemic stroke. Therefore, the selection of molecules and cell types that regulate cytokine production is important. Considering that the increase and infiltration of activated microglia/macrophages (M/M) is the major pathological change in ischemic stroke in humans and that DAMP/toll-like receptor (TLR) signaling is the starting point for microglial activation, the regulation of TLR signaling in M/M may be an important therapeutic strategy in the management of ischemic stroke.
No takes yet. Share an insight, caveat, or question.
Shimamura et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: